Peptide length variants p2Ca and QL9 present distinct conformations to Ld-specific T cells

Journal of Immunology

Volumn 167, Issue 8, 2001, Pages 4207-4214

  Hornell, T M C ^a   Martin, S M ^a   Myers, N B ^a   Connolly, J M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; EPITOPE; GLUTAMINE; MAJOR HISTOCOMPATIBILITY ANTIGEN; PEPTIDE FRAGMENT; PEPTIDE P2CA; PEPTIDE QL9; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; CELL SPECIFICITY; COMPLEX FORMATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR CLONING; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; T LYMPHOCYTE;

EID: 0035887759     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.8.4207     Document Type: Article

References (53)

1. Naturally-occurring peptide antigens derived from the MHC class-I-restricted processing pathway
2. Structure of the human class I histocompatibility antigen, HLA-A2
3. b molecule containing a single viral peptide: Implications for peptide binding and T-cell receptor recognition
4. b
5. b at 2A Å resolution: Implications for antigen-determinant selection
6. b-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove
7. An altered position of the α2 helix of MHC class 1 is revealed by the crystal structure of HLA-B*3501
8. Bound water structure and polymorphic amino acids act together to allow the binding of different peptides to MHC class I HLA-B53
9. Design and evaluation of antigen-specific vaccination strategies against cancer
10. Rational antigen modification as a strategy to upregulate or downregulate antigen recognition
11. d: Sequence motif, quantitative, binding, and molecular modeling of the complex
12. d by cytolytic T cells
13. A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes
14. d ligands lacking the consensus P2 anchor
15. + cytotoxic T lymphocytes in association with a class I MHC protein
16. + T-cell clone
17. High-affinity reactions between antigenspecific T-cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class I proteins
18. Kinetics and affinity of reactions between an antigen-specific T cell receptor and peptide-MHC complexes
19. + cytotoxic T lymphocytes
20. αβ T cell receptor interactions with syngeneic and allogeneic ligands: Affinity measurements and crystallization
21. d peptide complexes
22. d resulting in positive versus negative selection of the 2C transgenic T cell receptor in vivo
23. Differences in the level of expression of class I major histocompatibility complex proteins on thymic epithelial and dendritic cells influence the decision of immature thymocytes between positive and negative selection
24. Role of 2C T cell receptor residues in the binding of self- and allo-major histocompatibility complexes
25. Degenerate recognition of alloantigenic peptides on a positive-selecting class I molecule
26. An αβ T cell receptor structure at 2.5 Å and its orientation in the TCR-MHC complex
27. 2 microglobulin and peptide
28. Peptide antagonism and T cell receptor interactions with peptide-MHC complexes
29. Alanine scanning mutagenesis of an αβ T cell receptor: Mapping the energy of antigen recognition
30. d and the T cell receptor
31. Solid phase peptide synthesis 1. The synthesis of a tetrapeptide
32. Automated synthesis of a C-terminal photoprobe using combined Fmoc and t-Boc synthesis strategies on a single automated peptide synthesizer
33. Alloreactive and syngeneic CTL are comparably dependent on interaction with MHC class I α-helical residues
34. Efficient cDNA expression vectors for stable and transient expression of HLA-DR in transfected fibroblast and lymphoid cells
35. d-restricted cytotoxic T lymphocytes
36. Alloreactive cytotoxic T lymphocytes generated in the presence of viral-derived peptides show exquisite peptide and MHC specificity
37. Generation of cytotoxic T-lymphocytes to a self-peptide/class 1 complex: A model for peptide-mediated tumor rejection
38. d class I MHC molecule
39. d in cell lysates and the cell surface
40. - strains
41. Lack of strict correlation of functional sensitization with the apparent affinity of MHC/peptide complexes for the TCR
42. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2
43. The antigenic identity of peptide-MHC complexes: A comparison of the conformations of five viral peptides presented by HLA-A2
44. b heterodimer is restricted to peptides extended at their C terminus: Refinement of the inherent MHC class I peptide binding criteria
45. Three-dimensional structure of a peptide extending from one end of a class I MHC binding site
46. The structure and stability of an HLA-A*0202/octameric Tax peptide complex with an empty conserved peptide-N-terminal binding site
47. Effects of peptide length and composition on binding to an empty class I MHC heterodimer
48. Major histocompatibility complex and T cell receptor interaction of the P91A tumpeptide
49. Crystal structures of HLA-A*0201 complexed with either the amino- or carboxyl-terminal group substituted by a methyl group
50. Analysis of peptide residues interacting with MHC molecule or T cell receptor: Can a peptide bind in more than one way to the same MHC molecule?
51. Analysis of peptide binding patterns in different major histocompatibility complex/T cell receptor complexes using pigeon cytochrome c-specific T cell hybridomas: Evidence that a single peptide binds major histocompatibility complex in different conformations
52. d protein using two functionally distinct registers
53. DO11.10 and OT-11 T cells recognize a C-terminal ovalbumin 323-339 epitope